A Prospective, Single-Arm, Exploratory Study of IBI363 in ES-SCLC Patients After Immunotherapy Progression

Clinical trial NCT07289048 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07289048
Sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Status: NOT_YET_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

SCLC,Extensive Stage

Start date: 2025-12-20
Primary completion: 2027-12-30
Enrollment: 35

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.